anti-Campylobacter jejuni antibody product blog
Tags: Antibody; Polyclonal Antibody; Campylobacter jejuni; anti-CAMPYLOBACTER JEJUNI antibody;
The Campylobacter jejuni n/a (Catalog #MBS535024) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Campylobacter jejuni antibody (FITC) reacts with Campylobacter jejuni and may cross-react with other species as described in the data sheet. MyBioSource\'s Campylobacter jejuni can be used in a range of immunoassay formats including, but not limited to, User optimized. Researchers should empirically determine the suitability of the Campylobacter jejuni n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Rabbit polyclonal Campylobacter jejuni antibody (FITC) conjugated.
Biological Significance: Campylobacter jejuni is a species of curved, helical shaped, non-spore forming, Gram-negative microaerophilic, bacteria commonly found in animal feces. It is one of the most common causes of human gastroenteritis in the world. Biohazard Information: This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Tag/Conjugate: FITC
Immunogen: Campylobacter jejuni antibody (FITC) was raised in rabbit using strain 29428 as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Campylobacter jejuni are readily searchable from our website. Different antibodies against the same target such as Campylobacter jejuni may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.